Published in Retina on September 01, 2012
A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit). Graefes Arch Clin Exp Ophthalmol (2016) 0.84
Prevalence of vitreomacular adhesion: an optical coherence tomography analysis in the retina clinic setting. Clin Ophthalmol (2016) 0.75
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology (2003) 8.98
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med (2012) 8.83
A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol (2009) 6.32
Automated 3-D intraretinal layer segmentation of macular spectral-domain optical coherence tomography images. IEEE Trans Med Imaging (2009) 4.96
Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina (2009) 4.72
Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol (2009) 4.39
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Intraretinal layer segmentation of macular optical coherence tomography images using optimal 3-D graph search. IEEE Trans Med Imaging (2008) 3.68
Evolving guidelines for intravitreous injections. Retina (2004) 3.39
Corticosteroids and central serous chorioretinopathy. Ophthalmology (2002) 3.37
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina (2006) 3.29
Fundus autofluorescence imaging: review and perspectives. Retina (2008) 3.22
Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med (2004) 3.15
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina (2006) 3.09
Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol (2002) 2.95
Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina (2003) 2.90
Diagnostic and therapeutic challenges. Retina (2006) 2.80
Enhanced depth imaging optical coherence tomography of the sclera in dome-shaped macula. Am J Ophthalmol (2010) 2.64
Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology (2010) 2.61
Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci (2011) 2.53
Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina (2013) 2.49
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Am J Ophthalmol (2013) 2.45
Retracted Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization. Retina (2004) 2.43
Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology (2010) 2.39
The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology (2013) 2.35
Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet (2004) 2.30
Epiretinal proliferation seen in association with lamellar macular holes: a distinct clinical entity. Retina (2014) 2.27
Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina (2011) 2.22
Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol (2009) 2.22
Human chorioretinal layer thicknesses measured in macula-wide, high-resolution histologic sections. Invest Ophthalmol Vis Sci (2011) 2.13
Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery. J Cataract Refract Surg (2013) 2.12
The expanded spectrum of focal choroidal excavation. Arch Ophthalmol (2011) 2.11
Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol (2009) 2.06
Ophthalmic fundus imaging: today and beyond. Am J Ophthalmol (2004) 2.03
Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology (2009) 2.02
Evaluation of a system for automatic detection of diabetic retinopathy from color fundus photographs in a large population of patients with diabetes. Diabetes Care (2007) 1.98
Outcomes of 77 consecutive cases of 23-gauge transconjunctival vitrectomy surgery for posterior segment disease. Ophthalmology (2007) 1.98
Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol (2008) 1.92
Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.92
Full-thickness macular hole formation in idiopathic parafoveal telangiectasis. Retina (2007) 1.91
Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial. Ophthalmology (2009) 1.90
Fundus autofluorescence in patients with pseudoxanthoma elasticum. Ophthalmology (2006) 1.87
Coats' disease diagnosed in adulthood. Ophthalmology (2005) 1.84
Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. Lancet (2009) 1.83
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol (2010) 1.82
Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology (2005) 1.80
LONG-TERM FOLLOW-UP OF INTRAOCULAR PRESSURE AFTER VITRECTOMY IN EYES WITHOUT PREEXISTING GLAUCOMA. Retina (2015) 1.76
The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol (2003) 1.74
Imaging pulsatile retinal blood flow in human eye. J Biomed Opt (2008) 1.73
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol (2009) 1.72
Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina (2007) 1.71
Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol (2013) 1.71
Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular holes: a consecutive analysis of 100 cases. Am J Ophthalmol (2006) 1.66
Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol (2004) 1.65
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol (2009) 1.64
Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes. Ophthalmology (2006) 1.62
Ultrastructural correlation of spectral-domain optical coherence tomographic findings in vitreomacular traction syndrome. Am J Ophthalmol (2008) 1.60
A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci (2009) 1.60
Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol (2008) 1.60
How it appears: electron microscopic evaluation of internal limiting membrane specimens obtained during brilliant blue G assisted macular hole surgery. Br J Ophthalmol (2008) 1.59
Automated detection and differentiation of drusen, exudates, and cotton-wool spots in digital color fundus photographs for diabetic retinopathy diagnosis. Invest Ophthalmol Vis Sci (2007) 1.58
Vitrectomy does not increase the risk of open-angle glaucoma or ocular hypertension--a 5-year follow-up. Graefes Arch Clin Exp Ophthalmol (2010) 1.57
High-resolution optical coherence tomography findings in optic pit maculopathy. Retina (2010) 1.56
Long-term functional outcome of macular hole surgery correlated to optical coherence tomography measurements. Clin Experiment Ophthalmol (2007) 1.56
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina (2010) 1.56
Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina (2003) 1.53
Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II. Ophthalmology (2002) 1.52
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology (2013) 1.52
Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery. Eur J Ophthalmol (2009) 1.52
Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci (2003) 1.50
Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina (2013) 1.49
Intravitreal bevacizumab (Avastin) treatment is safe in terms of intraocular and blood pressure. Acta Ophthalmol Scand (2007) 1.49
Real-time intraocular pressure measurement in standard and microcoaxial phacoemulsification. J Cataract Refract Surg (2010) 1.48
Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. Am J Ophthalmol (2010) 1.47
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol (2011) 1.46
Sutureless 23-gauge versus 20-gauge vitrectomy with silicone oil injection in rhegmatogenous retinal detachment. Retina (2012) 1.46
Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci (2011) 1.46
Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina (2005) 1.45
Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol (2002) 1.45
Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap). Graefes Arch Clin Exp Ophthalmol (2007) 1.45
Disruption of the photoreceptor inner segment-outer segment junction in eyes with macular holes. Retina (2008) 1.44
Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina (2007) 1.44
Fundus autofluorescence and optical coherence tomographic findings in acute zonal occult outer retinopathy. Retina (2010) 1.44
Indocyanine green for successful repair of a long-standing macular hole. Am J Ophthalmol (2003) 1.42
Combined central retinal vein and artery occlusion associated with an isolated superior ophthalmic vein thrombosis. Retina (2004) 1.41